Pellegrini G, Seol Y J, Gruber R, Giannobile W V
Department Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI 48106, USA.
J Dent Res. 2009 Dec;88(12):1065-76. doi: 10.1177/0022034509349748. Epub 2009 Nov 3.
The development of new medical formulations (NMF) for reconstructive therapies has considerably improved the available treatment options for individuals requiring periodontal repair or oral implant rehabilitation. Progress in tissue engineering and regenerative medicine modalities strongly depends on validated pre-clinical research. Pre-clinical testing has contributed to the recent approval of NMF such as GEM 21S and INFUSE bone grafts for periodontal and oral regenerative therapies. However, the selection of a suitable pre-clinical model for evaluation of the safety and efficacy of a NMF remains a challenge. This review is designed to serve as a primer to choose the appropriate pre-clinical models for the evaluation of NMF in situations requiring periodontal or oral reconstruction. Here, we summarize commonly used pre-clinical models and provide examples of screening and functional studies of NMF that can be translated into clinical use.
用于重建治疗的新型医学制剂(NMF)的开发,极大地改善了需要牙周修复或口腔种植修复的个体的现有治疗选择。组织工程和再生医学模式的进展在很大程度上依赖于经过验证的临床前研究。临床前测试促成了近期如GEM 21S和INFUSE骨移植等NMF被批准用于牙周和口腔再生治疗。然而,选择合适的临床前模型来评估NMF的安全性和有效性仍然是一项挑战。本综述旨在作为一份入门指南,以便在需要牙周或口腔重建的情况下选择合适的临床前模型来评估NMF。在此,我们总结了常用的临床前模型,并提供了可转化为临床应用的NMF筛选和功能研究的实例。